Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal (Q44520753)

3 December 2017

title

Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal (English)

1 reference

3 December 2017

author name string

Elisabeth Deniaud-Alexandre

1

1 reference

3 December 2017

Emmanuel Touboul

2

1 reference

3 December 2017

Emmanuel Tiret

3

1 reference

3 December 2017

Alain Sezeur

4

1 reference

3 December 2017

Sidney Houry

5

1 reference

3 December 2017

Denis Gallot

6

1 reference

3 December 2017

Roland Parc

7

1 reference

3 December 2017

Rong Huang

8

1 reference

3 December 2017

Shuo-He Qu

9

1 reference

3 December 2017

Judith Huart

10

1 reference

3 December 2017

Françoise Pène

11

1 reference

3 December 2017

Michel Schlienger

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

International Journal of Radiation Oncology Biology Physics

3 December 2017

published in

1 reference

3 December 2017

volume

56

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

1259-1273

1 reference

Epidermoid carcinoma of the anal canal. A series of 276 cases

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Treatment of epidermoid anal canal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Squamous cell carcinoma of the anal canal: treatment by external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Primary radiation therapy in the treatment of anal canal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Radiation treatment of epidermoid cancer of the anus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Radiation therapy in the conservative treatment of carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Conservative versus nonconservative treatment of epidermoid carcinoma of the anal canal for tumors longer than or equal to 5 centimeters. A retrospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Ten-year results of chemoradiation for anal cancer: focus on late morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

The Paris system in interstitial radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

LENT SOMA scales for all anatomic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Results of salvage abdominoperineal resection for anal cancer after radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Time-dose considerations in the treatment of anal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900417-6

7 January 2021

10.1016/S0360-3016(03)00417-6

Identifiers

DOI

1 reference

3 December 2017

1 reference